iifl-logo

Welcure Drugs & Pharmaceuticals Ltd Board Meeting

11.67
(1.30%)
Jun 2, 2025|01:19:00 PM

Welcure Drugs CORPORATE ACTIONS

02/06/2024calendar-icon
02/06/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting29 May 202520 May 2025
Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March 2025. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March 2025. 3. To consider and approve the Audited Financial Statements including the Balance Sheet as at 31st March 2025 and the Statement of Profits and Loss and Cash flow statement of change in equity and notes thereon for the year ended 31st March 2025. 4. To Appoint Vishakha Agrawal & Associates Practicing Company Secretaries as the Secretarial Auditor of the Company for FY 2024-25. 5. Any other business with permission of the Chairman.
Board Meeting14 May 20259 May 2025
Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve To consider the appointment of Mr. Chintan Didawala Ganpat (DIN: 11088268) as Managing Director of the Company. 2. To consider the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects. 3. To consider the Increase in the Authorized Share Capital of the Company and consequent amendment in Memorandum of the Company if any; 4. Conduct Postal Ballot by means of E-voting for obtaining approval of the members of the Company Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited Amendments to Memorandum of Association (As Per BSE Announcement Dated on 14.05.2025)
Board Meeting6 May 20256 May 2025
Outcome of the Meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Ltd.held on today i.e Tuesday 06th May 2025
Board Meeting14 Feb 202510 Feb 2025
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Intimation of meeting of BOD under regulation 29 of the SEBI(LODR) Regulation 2015. Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Friday 14 February, 2025. OUTCOME OF THE MEETING OF THE BOARD OF DIRECTORS OF WELCURE DRUGS AND PHARMACEUTICALS LIMITED HELD ON TODAY 14 FEBRUARY 2025. (As Per BSE Announcement Dated on 14.02.2025)
Board Meeting22 Jan 202522 Jan 2025
Outcome of the meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Wednesday, 22nd January, 2025
Board Meeting2 Dec 20242 Dec 2024
Outcome of the meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd. held on today i.e. Monday, 02nd December, 2024.
Board Meeting14 Nov 20247 Nov 2024
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the 2nd quarter and half year ended on 30th September 2024 WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Board Meeting has been postponed and rescheduled to be held on Thursday, 14th November, 2024. (As per BSE Announcement Dated on 13/11/2024) Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on today i.e. Thursday, 14th November, 2024. (As Per BSE Announcement dated on 14.11.2024)
Board Meeting21 Oct 202417 Oct 2024
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2024 inter alia to consider and approve Forfeiture of 153900 Partly Paid-up Equity Shares. Outcome of Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd. (As Per BSE Announcement Dated on 21.10.2024)
Board Meeting4 Oct 20244 Oct 2024
Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited.
Board Meeting2 Sep 202429 Aug 2024
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 inter alia to consider and approve Intimation of meeting of the Board of Directors under the Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Outcome of Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited (As per BSE Announcement Dated on 02/09/2024)
Board Meeting14 Aug 20246 Aug 2024
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Board Meeting Intimation Unaudited Fin Result along with Limited Review Report (As Per Bse Announcement Dated on 14.08.2024)
Board Meeting8 Aug 20248 Aug 2024
Conversion of 3,29,99,997 warrants into equal number of equity shares of the Company on preferential basis
Board Meeting24 Jul 202424 Jul 2024
Conversion of 3,30,00,000 warrants into equal number of equity shares of the Company on preferential basis
Board Meeting18 Jul 202418 Jul 2024
Allotment of 9,90,00,000 Fully Convertible Warrants at Issue Price of Rs. 10/- on preferential basis
Board Meeting10 Jun 20245 Jun 2024
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2024 inter alia to consider and approve with reference to augment of financial resources of the company to increase in authorised share capital of the company and to shift branch office of the company. Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd. held on today i.e. Monday, June 10, 2024. (As Per BSE Announcement dated on 10.06.2024)

Welcure Drugs: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.